相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Improved Treatment Outcomes With Bedaquiline When Substituted for Second-line Injectable Agents in Multidrug-resistant Tuberculosis: A Retrospective Cohort Study
Ying Zhao et al.
CLINICAL INFECTIOUS DISEASES (2019)
A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis
Andrew J. Nunn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Evolution of Programmatic Definitions Used in Tuberculosis Prevention and Care
G. B. Migliori
CLINICAL INFECTIOUS DISEASES (2019)
Introducing molecular testing of pyrazinamide susceptibility improves multidrug-resistant tuberculosis treatment outcomes: a prospective cohort study
Feng Sun et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review
Emanuele Pontali et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Whole genome sequencing of Mycobacterium tuberculosis
Andrea M. Cabibbe et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis
Nafees Ahmad et al.
LANCET (2018)
Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase
Matthew Ezewudo et al.
SCIENTIFIC REPORTS (2018)
High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen
Norbert Ndjeka et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
QTc and anti-tuberculosis drugs: a perfect storm or a tempest in a teacup? Review of evidence and a risk assessment
I. Monedero-Recuero et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2018)
Global TB Network: working together to eliminate tuberculosis
Denise Rossato Silva et al.
JORNAL BRASILEIRO DE PNEUMOLOGIA (2018)
Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study
Ndivhuho A. Makhado et al.
LANCET INFECTIOUS DISEASES (2018)
Cardiac safety of bedaquiline: a systematic and critical analysis of the evidence
Emanuele Pontali et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Shorter regimens for multidrug-resistant tuberculosis should also be applicable in Europe
Marieke J. van der Werf et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study
Sergey E. Borisov et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Resistance profile of drugs composing the shorter regimen for multidrug-resistant tuberculosis in Brazil, 2000-2015
Margareth Dalcolmo et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Effectiveness and safety of clofazimine in multidrug-resistant tuberculosis: a nationwide report from Brazil
Margareth Dalcolmo et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update
Dennis Falzon et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Applicability of the shorter 'Bangladesh regimen' in high multidrug- resistant tuberculosis settings
Giovanni Sotgiu et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
Multidrug-resistant TB in Eastern region of the EU: is the shorter regimen an exception or a rule?
Yanina Balabanova et al.
THORAX (2017)
Half of rifampicin-resistant Mycobacterium tuberculosis complex isolated from tuberculosis patients in Sub-Saharan Africa have concomitant resistance to pyrazinamide
Jean Claude Semuto Ngabonziza et al.
PLOS ONE (2017)
Six-Month Response to Delamanid Treatment in MDR TB Patients
Cathy Hewison et al.
EMERGING INFECTIOUS DISEASES (2017)
Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project
Matteo Zignol et al.
LANCET INFECTIOUS DISEASES (2016)
A mutation associated with clofazimine and bedaquiline cross-resistance in MDR-TB following bedaquiline treatment
Akos Somoskovi et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis
Mayara L. Bastos et al.
CLINICAL INFECTIOUS DISEASES (2014)
Successful '9-month Bangladesh regimen' for multidrug-resistant tuberculosis among over 500 consecutive patients
K. J. M. Aung et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2014)
High cure rate with standardised short-course multidrug-resistant tuberculosis treatment in Niger: no relapses
A. Piubello et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2014)
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
D. Falzon et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis
Armand Van Deun et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Increasing transparency in partnerships for health - introducing the Green Light Committee
R Gupta et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2002)
分享论文
